02186 綠葉製藥
公司資料 - 股權變動
日期 股東名稱 披露原因 買入/賣出涉及
的股份數目
每股平均價 持有權益的
股份數目
佔已發行
股本(%)
03/01/2025UBS Group AG1305(L)68,623,827(L)456,292,400(L)
360,935,000(S)
12.13
9.60
02/01/2025UBS Group AG1104(L)
1502(S)
+9,105,000(L)
-82,994,302(S)
460,222,164(L)
365,536,264(S)
12.23
9.72
26/12/2024UBS Group AG1205(L)-499,083(L)451,269,014(L)
449,603,523(S)
11.99
11.95
25/12/2024UBS Group AG1104(L)+877,500(L)451,690,097(L)
450,006,098(S)
12.01
11.96
24/12/2024UBS Group AG1205(L)
1502(S)
-9,398,369(L)
-9,398,369(S)
444,198,366(L)
442,514,367(S)
11.81
11.76
20/12/2024UBS Group AG1402(S)+2,693,500(S)456,601,225(L)
453,596,218(S)
12.14
12.06
19/12/2024UBS Group AG1306(L)165,000,000(L)452,764,210(L)
447,053,714(S)
12.04
11.88
18/12/2024Shorea LBG1101(L)+2,000,000(L)HKD 2.230(L)1,261,196,703(L)
192,317,950(S)
33.53
5.11
18/12/2024Luye Life Sciences Group Ltd1101(L)+2,000,000(L)HKD 2.230(L)1,261,196,703(L)
192,317,950(S)
33.53
5.11
18/12/2024LuYe Pharmaceutical Investment Co., Ltd.1101(L)+2,000,000(L)HKD 2.230(L)1,261,196,703(L)
192,317,950(S)
33.53
5.11
18/12/2024Luye Pharma Holdings Ltd.1101(L)+2,000,000(L)HKD 2.230(L)1,261,196,703(L)
192,317,950(S)
33.53
5.11
18/12/2024刘殿波1101(L)+2,000,000(L)HKD 2.230(L)1,261,196,703(L)
192,317,950(S)
33.53
5.11
18/12/2024UBS Group AG1502(S)-3,089,369(S)460,943,069(L)
448,320,669(S)
12.25
11.92
18/12/2024Ginkgo (PTC) Limited1101(L)+2,000,000(L)HKD 2.230(L)1,261,196,703(L)
192,317,950(S)
33.53
5.11
18/12/2024LuYe Pharmaceutical International Co., Ltd.1101(L)+2,000,000(L)HKD 2.230(L)1,261,196,703(L)
192,317,950(S)
33.53
5.11
18/12/2024Nelumbo Investments Limited1101(L)+2,000,000(L)HKD 2.230(L)1,261,196,703(L)
192,317,950(S)
33.53
5.11
13/12/2024Kale Asset Holding Ltd1316(L)105,838,779(L)317,516,338(L)8.44
13/12/2024RRJ Capital Master Fund IV, L.P.1316(L)105,838,779(L)317,516,338(L)8.44
13/12/2024RRJ Capital IV Ltd1316(L)105,838,779(L)317,516,338(L)8.44
13/12/2024Ong Tiong Sin1316(L)105,838,779(L)317,516,338(L)8.44
12/12/2024UBS Group AG1402(S)+3,166,000(S)463,296,075(L)
454,292,599(S)
12.32
12.08
11/12/2024UBS Group AG1502(S)-6,942,871(S)451,484,577(L)
444,486,613(S)
12.00
11.82
10/12/2024UBS Group AG1402(S)+2,390,000(S)461,242,758(L)
453,276,294(S)
12.26
12.05
05/12/2024UBS Group AG1113(L)+4,243,310(L)455,641,276(L)
448,552,424(S)
12.11
11.92
28/11/2024UBS Group AG1205(L)-722,500(L)450,942,536(L)
446,040,510(S)
11.99
11.86
26/11/2024UBS Group AG1314(L)3,039,764(L)452,262,450(L)
445,784,924(S)
12.02
11.85
14/11/2024UBS Group AG1502(S)-4,011,014(S)457,189,858(L)
448,190,442(S)
12.15
11.91
06/11/2024UBS Group AG1305(L)327,000(L)462,081,039(L)
453,031,543(S)
12.28
12.04
30/10/2024Ong Tiong Sin1316(L)211,677,559(L)317,516,338(L)8.44
30/10/2024Kale Asset Holding Ltd1316(L)211,677,559(L)317,516,338(L)8.44
30/10/2024RRJ Capital Master Fund IV, L.P.1316(L)211,677,559(L)317,516,338(L)8.44
30/10/2024RRJ Capital IV Ltd1316(L)211,677,559(L)317,516,338(L)8.44
25/10/2024UBS Group AG1306(L)4,522,002(L)477,140,083(L)
476,646,199(S)
12.68
12.67
22/10/2024RRJ Capital Master Fund IV, L.P.11035(L)+317,516,338(L)317,516,338(L)8.44
22/10/2024RRJ Capital IV Ltd11035(L)+317,516,338(L)317,516,338(L)8.44
22/10/2024Ong Tiong Sin11035(L)+317,516,338(L)317,516,338(L)8.44
22/10/2024Kale Asset Holding Ltd11035(L)+317,516,338(L)317,516,338(L)8.44
14/10/2024UBS Group AG1305(L)10,809,221(L)469,754,294(L)
471,057,914(S)
12.49
12.52
09/10/2024UBS Group AG1305(L)10,522,660(L)480,859,970(L)
481,084,583(S)
12.78
12.79
02/10/2024UBS Group AG1205(L)-1,388,000(L)487,978,842(L)
484,376,312(S)
12.97
12.88
  1    2    3    4    5    6    7   8    9  
備註: (L) - 長倉:包括 (1) 持有股份;(2) 透過持有、沽出或發行金融合約,有權或有責任購買相關股份。
  (S) - 短倉:包括 (1) 借入股份;(2) 透過持有、沽出或發行金融合約,有權或有責任沽出相關股份。
  (P) - 可供借出的股份
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.